Dáil Éireann Debate, Thursday - 17 July 2014
732. Deputy Micheál Martin asked the Minister for Health his plans to add chronic obstructive pulmonary disease to the long-term illness scheme; if it is a condition that will be considered in terms of granting a medical card based on clinical need; and if he will make a statement on the matter. [32827/14]
View answerThe Long Term Illness (LTI) Scheme was established under Section 59(3) of the Health Act, 1970 (as amended). Regulations were made in 1971, 1973 and 1975 specifying the conditions covered by the LTI Scheme. The conditions covered by the LTI Scheme are as follows: Acute Leukaemia; Mental handicap; Cerebral Palsy; Mental Illness (in a person under 16); Cystic Fibrosis; Multiple Sclerosis; Diabetes Insipidus; Muscular Dystrophies; Diabetes Mellitus; Parkinsonism; Epilepsy; Phenylketonuria; Haemophilia; Spina Bifida; Hydrocephalus; and conditions arising from the use of Thalidomide. There are no plans to extend the list of conditions covered by the LTI Scheme.
Under the Drug Payment Scheme, no individual or family pays more than €144 per calendar month towards the cost of approved prescribed medicines. The scheme significantly reduces the cost burden for families and individuals incurring ongoing expenditure on medicines. Under the provisions of the Health Acts, medical cards are provided to persons who are, in the opinion of the Health Service Executive (HSE), unable without undue hardship to arrange GP services for themselves and their dependants. In the assessment process, the HSE can take into account medical costs incurred by an individual or a family.
The Government has decided to develop a new policy framework providing for eligibility for a range of appropriate health services to take account of medical conditions. The HSE has established an Expert Panel to examine the range of conditions and services that should be considered as part of this process. A public consultation has also been undertaken to seek the views of the public, including patients, patient representative groups and professional bodies. The submissions received will inform the work of the Expert Panel. The panel has been asked to report to the Director General of the Health Service by September 2014.
